David LeDuc
Director of Global Oncology Policy, Patient Advocacy and Health Equity
AstraZeneca
US
David serves as Director of Global Oncology Policy, Patient Advocacy and Health Equity at AstraZeneca, with a focus on lung cancer. He is responsible for ensuring that the patient voice is represented in all aspects of AstraZeneca’s work, with an emphasis on patient involvement in access advocacy.
Prior to joining AstraZeneca, David spent 20 years working in the non-profit sector, most recently at the GO2 Foundation, where he developed the Lung Cancer Registry.